Comparison of atrial natriuretic peptide, brain natriuretic peptide, C-natriuretic peptide, adrenomedullin, N-terminal proatrial and probrain natriuretic peptides as indicators of early congestive heart failure
Daggubati, S.; Parks, J.R.; Overton, R.M.; Cintron, G.; Schocken, D.D.; Vesely, D.L.
Journal of Investigative Medicine 45(3): 211A
1997
ISSN/ISBN: 1081-5589 Accession: 030633158
Full Text Article emailed within 1 workday
Payments are secure & encrypted
Related References
Arakawa, K.; Ando, Y.; Matsunaga, S.; Nishiura, A. 2016: Diagnostic Ability of Natriuretic Peptides for Heart Failure According to eGFR Level: Comparison between Brain Natriuretic Peptide and Amino-Terminal Probrain Natriuretic Peptide Rinsho Byori. Japanese Journal of Clinical Pathology 64(3): 251-257Hülsmann, M.; Berger, R.; Mörtl, D.; Gore, O.; Meyer, B.; Pacher, R. 2005: Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide European Journal of Heart Failure 7(4): 552-556
Davidson, N.C.; Naas, A.A.; Hanson, J.K.; Kennedy, N.S.; Coutie, W.J.; Struthers, A.D. 1996: Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction American Journal of Cardiology 77(10): 828-831
Dong, H.; Chen, D.-q.; Wang, Y.; Li, M. 2008: Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure Nan Fang Yi Ke da Xue Xue Bao 28(9): 1740-1742
Nishikimi, T.; Mori, Y.; Ishimura, K.; Tadokoro, K.; Yagi, H.; Yabe, A.; Horinaka, S.; Matsuoka, H. 2004: Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function American Journal of Medicine 116(8): 517-523
Omland, T.; Aakvaag, A.; Bonarjee, V.V.; Caidahl, K.; Lie, R.T.; Nilsen, D.W.; Sundsfjord, J.A.; Dickstein, K. 1996: Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93(11): 1963-1969
Omland, T.; Aakvaag, A.; Bonarjee, V.V.S.; Caidahl, K.; Lie, R.T.; Nilsen, D.W.T.; Sundsfjord, J.A.; Dickstein, K. 1996: Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction : Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93(11): 1963-1969
Takashio, S.; Takahama, H.; Nishikimi, T.; Hayashi, T.; Nagai-Okatani, C.; Matsuo, A.; Nakagawa, Y.; Amano, M.; Hamatani, Y.; Okada, A.; Amaki, M.; Hasegawa, T.; Kanzaki, H.; Yasuda, S.; Kangawa, K.; Anzai, T.; Minamino, N.; Izumi, C. 2019: Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms Open Heart 6(2): E001072
Selvais, P.L.; Robert, A.; Ahn, S.; van Linden, F.; Ketelslegers, J.M.; Pouleur, H.; Rousseau, M.F. 2000: Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure Journal of Cardiac Failure 6(3): 201-207
Li, Y.-j.; Wang, L.; Chen, K.-y.; Chen, Y.-l.; Cai, J.-r.; Zhou, L.-j. 2005: Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 17(9): 544-547
Prontera, C.; Emdin, M.; Zucchelli, G.C.; Ripoli, A.; Passino, C.; Clerico, A. 2004: Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide Clinical Chemistry and Laboratory Medicine 42(1): 37-44
Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; MacGregor, G.A. 1994: N-terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma: investigation of plasma levels and molecular circulating form(s) using radioimmunoassays for pro-atrial natriuretic peptide (31-67), pro-atrial natriuretic peptide (1-30) and atrial natriuretic peptide (99-126) Clinical Science 87(3): 311-317
Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; Macgregor, G.A. 1994: N-terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma : investigation of plasma levels and molecular circulating form(s) using radioimmunoassays for pro-atrial natriuretic peptide (31-67), pro-atrial natriuretic peptide (1-30) and atrial natriuretic peptide (99-126) Clinical Science (1979) 87(3): 311-317
Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; Macgregor, G.A. 1994: N-Terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma Investigation of plasma levels and molecular circulating form using radioimmunoassays for pro-atrial natriuretic peptide , pro-atrial natriuretic peptide and atrial natriuretic peptide Clinical Science 87(3): 311-317
Bertinchant, J-Pierre.; Combes, N.; Polge, A.; Fabbro-Peray, P.; Raczka, F.; Beck, L.; Cade, Séphane.; Ledermann, B. 2005: Prognostic value of cardiac troponin T in patients with both acute and chronic stable congestive heart failure: comparison with atrial natriuretic peptide, brain natriuretic peptide and plasma norepinephrine Clinica Chimica Acta; International Journal of Clinical Chemistry 352(1-2): 143-153
Zaphiriou, A.; Robb, S.; Mendez, G.; Murray Thomas, T.; Hardman, S.M.C.; Mcdonagh, T.; Dargie, H.; Cowie, M.R. 2003: Using brain natriuretic peptide and N terminal pro-brain natriuretic peptide to rule out heart failure Does it work in clinical practice? Results of the UK natriuretic peptide Study European Heart Journal 24(Abstract Suppl): 260
Kanno, N.; Hori, Y.; Hidaka, Y.; Chikazawa, S.; Kanai, K.; Hoshi, F.; Itoh, N. 2016: Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure Journal of Veterinary Medical Science 78(4): 535-542
Metry, G.; Hall, C.; Wikström, B.; Källskog, V.; Hansell, P.; Danielson, B. 2001: Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography Acta Physiologica Scandinavica 171(2): 117-122
Yoshimura, M.; Yasue, H.; Okumura, K.; Ogawa, H.; Jougasaki, M.; Mukoyama, M.; Nakao, K.; Imura, H. 1993: Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure Circulation 87(2): 464-469
Mukoyama, M.; Nakao, K.; Hosoda, K.; Suga, S.; Saito, Y.; Ogawa, Y.; Shirakami, G.; Jougasaki, M.; Obata, K.; Yasue, H. 1991: Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide Journal of Clinical Investigation 87(4): 1402-1412